Amongst frantic media coverage of increases in cases of (RSV) among children, Pfizer has announced the development of an experimental bivalent RSV vaccine for pregnant mothers in an attempt to protect newborns from being infected with the virus. The pharmaceutical giant plans to submit the results of their RSV vaccine clinical trials to the U.S. Food and Drug Administration (FDA) for approval by the end of the year.1 In March 2022, the FDA designated Pfizer’s genetically engineered RSV vaccine as a “breakthrough therapy,” which will put the review process on a fast track to liensure.2
The vaccine will create a huge market for Pfizer as it will target not only pregnant women, but also infants and seniors. In a Nov. 1, 2022 press release, Pfizer stated, “Pfizer is currently the only company with an investigational vaccine being prepared for regulatory applications for both infants through maternal vaccination and older adults to help protect against RSV.”3
According to Pfizer, the company created the RSV vaccine based on “foundational basic science discoveries made at the National Institutes of Health (NIH), which detailed the crystal struc4ure of prefusion F, a key form of the viral fusion protein (F) that RSV uses to enter human cells,” and demonstrated that “antibodies specific to the prefusion form were highly effective at blocking virus infection.” The bivalent vaccine is composed of equal amounts of recombinant RSV prefusion from subgroups A and B.4
GlaxoSmithKline Halts Late Stage RSV Trials at Suggestion of Safety Committee
In February 2022, British drug maker GlaxoSmithKline halted late-stage trials on pregnant women for their RSV vaccine. The voluntary decision was made following a safety recommendation from the Independent Data Monitoring Committee. No further details were given on what prompted the recommendations and withdrawal. However, GlaxoSmithKline is continuing its clinical trials on an RSV vaccine for elderly adults.5
RSV Cases Mild in Majority of People
RSV mainly affects babies and children under the age of two and has circulated seasonally for decades. The virus is a common respiratory illness that causes mild, cold-like symptoms in most people. The U.S. Centers for Disease Control and Prevention (CDC) website states that almost all children have had an RSV infection by their second birthday and that most infections go away without complications on their own in one to two weeks. In cases where RSV infection becomes severe, it can lead to inflammation of the lungs and airway.6
Pfizer reported data from a phase three clinical trial of its experimental RSV vaccine earlier this month, which included administration of the vaccine to over 7,000 pregnant women and infants. The vaccine is supposed to produce antibodies in pregnant women that cross the placenta to passively transfer artificial immunity to RSV in the developing fetus. Pfizer claims the Phase 3 randomized, double-blind, placebo controlled clinical trial results demonstrated that the vaccine was 82 percent effective in preventing severe cases of RSV in infants through three months old. By six months old, effectiveness decreased to 69 percent in preventing RSV illness according to trial data.7
Experts Believe Lockdowns and Subsequent ‘Immunity Gap’ to Blame for RSV Increases
Some doctors believe the surge in RSV stems from an “immunity gap” that occurred due to public health response measures designed to limit the spread of SARS-CoV-2 including lockdowns, wearing masks, and physical distancing. An immunity gap or “immunity debt” occurs when individuals are not exposed to illnesses in a typical manner so natural immunity is never achieved. This tends to especially affect children, whose immune systems are maturing while they are being exposed to common types of viruses and bacteria.8 9
In a Lancet commentary, Kevin Messacar, MD and epidemiologist Rachel Baker, MPH wrote:
Decreased exposure to endemic viruses created an immunity gap–a group of susceptible individuals who avoided infection and therefore lack pathogen-specific immunity to protect against future infection.8
Baker told CNN News that respiratory disease outbreaks will get back to their more typical occurrence as long as there are no resurgences of SARS-CoV-2. “If the coronavirus gets bad enough that more lockdowns are necessary, it could once again throw off the seasonality of other viruses,” Baker said.8
Tylenol and Amoxicillin Shortages Contribute to Fear of RSV
While RSV infections are reportedly rising among children, news of drug shortages is contributing to the anxiety and fear many have been conditioned to feel about infectious diseases, especially over the past three years. Canada is reportedly experiencing a shortage of drugs to minimize fever and pain, such as Tylenol.10 Earlier this month, officials announced a worldwide shortage of the anti-bacterial drug, amoxicillin.
Drug shortages are said to be due to supply chain issues, which have been exacerbated by an increase in patients using the medications.11
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
Click here to view References:
1 Ramirez-Feldman L. Pfizer’s RSV vaccine for pregnant women protects newborns against severe illness. Yahoo News! Nov. 1, 2022.
2 Pfizer. Pfizer granted FDA breakthrough Therapy Designation for Respiratory Syncytial Virus (RSV) Vaccine Candidate for the Prevention of RSV in Infants from Birth up to Six Months of Age by Active Immunization of Pregnant Women. Mar. 2, 2022.
3 Press Release. Pfizer Announces Positive Top-Line Data of Phase 3 Global Maternal Immunization Trial for its Bivalent Respiratory Syncytial Virus (RSV) Vaccine Candidate. Pfizer Nov. 1, 2022.
5 Reuters. GSK halts three trials of respiratory virus vaccine in pregnant women. Feb. 28, 2022.
6 Respiratory Syncytial Virus. Centers for Disease Control and Prevention. Oct. 24, 2022.
7 Ramirez-Feldman L. Pfizer’s RSV vaccine for pregnant women protects newborns against severe illness. Yahoo News! Nov. 1, 2022.
8 Christensen J. Pandemic ‘immunity gap’ is probably behind surge in RSV cases, scientists say. CNN Oct. 28, 2022.
9 Kloc M, Ghobrial RM, Kuchar E et al. Development of child immunity in the context of COVID-19 pandemic. Clin Immunol 202; 217: 108510.
10 Staff. Drug shortages worsen across Canada, extend beyond kids’ pain and fever meds. The Canadian Press Nov. 15, 2022.
11 Stelloh T, Chow D. Amoxicillin in short supply, federal health officials say. NBC News Nov. 3, 2022.
We have been living with RSV for decades . So why use a dangerous ‘Fast Track’ ?
With high RSV this year the “Immunity gap” will be gone on 3 months.
When they 💉 pregnant moms, it will be difficult for babies to report adverse effects. Many adverse effects will not be reported.
Meaning that it will not be thoroughly tested or in legitimate trials. It will be labeled as safe and effective…the paramount big pharma lie for all their drugs.
Humans have to get sick sometimes,it’s the natural evolutionary process,a part of life.Why is it these companies think they need to profit from attempting to avoid natural sickness,natural immunity,& jeopardize unborn babies lives?
There is no RSV virus, just as there is no covid virus, no bird flu virus, no measles virus, no polio virus, etc., etc. There is only a vaccine, sickness induced by the vaccine, another toxic vaccine to “prevent” the vaccine-induced sickness, and so on ad infinitum. When will people start seeing what’s right in front of them? The globalist genocidal program was reduced to absurdity a long time ago.
Yes! Conveniently they began testing their RSV vaccine back in March when there were no cases of RSV.
What he said… 👍 #RockefellerMedicine
It has already been proven these vaccines do not protect from either infection or transmission.
The Flu, but just given a new name. People stopped getting the Flu shot because they realized it doesn’t work. They had to think of another way to scare Americans to gain control over their lives!
Wow!!! NO! Melinda MSN RN CNS
Same old method.
So now everything FDA / CDC says and does is an approval. Formal Approval versus Emergency Approval distinctions are no longer made. Yet – if recent history means anything, if anyone comes up with a cheap and readily available alternative to the “Vaccine,” they will be crucified and drummed out of the medical profession.
One thing you can be sure of, whatever FDA / CDC / NIH approves will also be with the provision that the developers and distributors will be immunized from legal action for any bad things caused by their products. That means that the “approval” must be based upon an “Emergency Utilization Approval (EUA).” I wonder what the emergency will be for this one? No emergency, no EUA, no vaccine. Formal approvals have now become obsolete, except to fake the public into thinking everything they are being subjected to is formally approved. Yay for Vaccine Mandates!
OOoops! I forgot. I’m gonna be moderated? I wasted my time.
I cannot imagine how anyone pregnant would think it’s ok to get vaccines of ANY kind during their pregnancy..let alone gene therapy/adenoviral vector or RSV experimental vaccines!!! Even the flu shots are using nanotechnology in them now!!
Any doctor or medical professional that pushes these toxic bioweapons onto pregnant, nursing, mothers needs to be in prison. Anyone that is ignorant enough to force this on their children needs to be locked up…what in the world are people thinking?? This is NOT about keeping people healthy, it is becoming obvious that it is about something else.. Wake the heck up!!
Never get a or any vaccine, while carrying life in the womb!